Navigoe Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95K Sell
104
-30
-22% -$30.4K 0.06% 61
2025
Q4
$144K Hold
134
0.09% 47
2025
Q3
$102K Buy
134
+33
+33% +$24.6K 0.07% 59
2025
Q2
$78K Hold
101
0.06% 58
2025
Q1
$83K Hold
101
0.07% 53
2024
Q4
$77K Buy
+101
New +$83.6K 0.08% 52

Other funds holding LLY

Navigoe Wealth Management's LLY Position: Q1 2026 in Review

Navigoe Wealth Management reduced its Eli Lilly (LLY) stake by 22% in Q1 2026, selling an estimated $30.4K and leaving 104 shares worth $95K. The position accounts for 0.06% of the portfolio, ranked #61.

Navigoe Wealth Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $144K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Navigoe Wealth Management held 104 shares of Eli Lilly worth $95K as of Q1 2026.
  • Navigoe Wealth Management sold 30 Eli Lilly shares in Q1 2026, an estimated $30.4K.
  • Eli Lilly made up 0.06% of Navigoe Wealth Management's portfolio in Q1 2026, its #61 holding.
  • Navigoe Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Navigoe Wealth Management's Eli Lilly position peaked at $144K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Navigoe Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.